Kamada Ltd.

Last updated
Kamada Ltd.
Company type Public
TASE:  KMDA
Nasdaq:  KMDA
Industry Pharmaceutical
Founded1990;34 years ago (1990)
Headquarters Rehovot, Israel
Key people
 Leon Recanati (chairman of the board)
Amir London (CEO)
ProductsGlassia, KamRAB, KamRho
Number of employees
316 (2001)
Website kamada.com

Kamada Ltd. is a biopharmaceutical company specializing in the development, manufacture and marketing of proteins as pharmaceuticals. The company's headquarters and laboratories are located in the park of Kiryat Weizmann Institute of Science in Rehovot. The production facility is located in Kibbutz Beit Kama.

Contents

The company produces about 10 injectable and marketed drugs in more than 15 countries.

History

Kamada was founded in 1990 by David Tzur, Ralph Hahn and Kamapharam Ltd., which was wholly owned by Kibbutz Beit Kama, until then Kamapharam was producing albumin, and its production facilities were acquired in full by Kamada In 1999, (35%) to a company owned by Hahn and another investor for $2.5 million. Hahn and Tzur headed the company by the beginning of 2013. The company completed its first public offering in 2005 on the Tel Aviv Stock Exchange. [1]

Today, the company specializes in the development, manufacture and marketing of proteins, especially for orphan diseases. The company produces about 10 injectable and marketed drugs in more than 15 countries around the world. [2]

Kamada is a member of the Biomed index on the Tel Aviv Stock Exchange, and as of December 2012, its shares were included in the Tel Aviv 100 index. [3]

In 2012, the company was ranked 456 among the 500 fastest growing companies in Europe (and 15th in Israel) according to the Deloitte Index, based on their income in 2007–2011. [4]

In May 2014, the company announced that it had not met the target set for the trial for a hereditary emphysema in inhalation. [5] Following the failure of the experiment, the company's market value fell within a year from $500 million to $150 million. [6]

Products

Alpha-1 anti-trypsin for infusion (AAT IV)

Kamada's flagship product is Glassia, approved by the FDA to treat alpha 1-antitrypsin deficiency. The active ingredient in the drug is the protein alpha-1 antitrypsin, for patients with a genetic deficiency in that protein. The firm has a strategic agreement with Baxter for the marketing, distribution and licensing of the drug in the United States. [7] [8]

Production of immunoglobulins

The company has developed a technological platform for the production of specific immunoglobulins (IgG's). It produces a specific antibody against the rabies virus, and a product for the treatment of HDN - disease of the newborn hemolytic (Hemolytic Disease of the Newborn) - a disease caused from Rh negative in the fetus.

The company cooperates with the Israeli Ministry of Health, in the framework of which it established a GMP standard for the production of serum against snake venom. The product is manufactured from the serum of hyper-immune horses . [9]

The company has a strategic agreement with Kedrion Pharmaceuticals for the development and marketing of the KamRab rabies immunoglobulin in the United States. [10]

See also

Related Research Articles

<span class="mw-page-title-main">Alpha-1 antitrypsin deficiency</span> Medical condition

Alpha-1 antitrypsin deficiency is a genetic disorder that may result in lung disease or liver disease. Onset of lung problems is typically between 20 and 50 years of age. This may result in shortness of breath, wheezing, or an increased risk of lung infections. Complications may include chronic obstructive pulmonary disease (COPD), cirrhosis, neonatal jaundice, or panniculitis.

<span class="mw-page-title-main">Alpha-1 antitrypsin</span> Mammalian protein found in Homo sapiens

Alpha-1 antitrypsin or α1-antitrypsin is a protein belonging to the serpin superfamily. It is encoded in humans by the SERPINA1 gene. A protease inhibitor, it is also known as alpha1–proteinase inhibitor (A1PI) or alpha1-antiproteinase (A1AP) because it inhibits various proteases. In older biomedical literature it was sometimes called serum trypsin inhibitor, because its capability as a trypsin inhibitor was a salient feature of its early study. As a type of enzyme inhibitor, it protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 0.9–2.3 g/L, but the concentration can rise manyfold upon acute inflammation.

<span class="mw-page-title-main">Nir Klinger</span> Israeli footballer and manager

Nir Klinger is an Israeli football coach and former player.

<span class="mw-page-title-main">ICL Group Ltd.</span> Global manufacturer of mineral based products

ICL Group Ltd. is a multi-national manufacturing concern that develops, produces and markets fertilizers, metals and other special-purpose chemical products. ICL serves primarily three markets: agriculture, food and engineered materials. ICL produces approximately a third of the world's bromine, and is the world's sixth-largest potash producer. It is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions.

Elco Ltd. is an international conglomerate holding company headquartered in Tel Aviv, Israel. The company was founded in 1949 by Alexander Salkind, and has been managed since its establishment by three generations of the Salkind family. It is the parent company of Electra, Electra Consumer Products, Electra Real Estate, Supergas and others. By 2021 the company’s subsidiaries were active in 17 countries, with more than 21,000 employees, and a production site in Israel where it manufactures air conditioning units and electromechanical equipment.

<span class="mw-page-title-main">BAZAN Group</span> Oil refining and petrochemicals company located in Haifa Bay, Israel

BAZAN Group,, formerly Oil Refineries Ltd., is an oil refining and petrochemicals company located in Haifa Bay, Israel. It operates the largest oil refinery in the country. ORL has a total oil refining capacity of approximately 9.8 million tons of crude oil per year with a Nelson complexity index of 9. ORL provides a variety of products used in industrial operations, agriculture and transportation. ORL is Israel's largest integrated refining and petrochemical facility. The company also provides storage and transportation services for oil fuel products, as well as electricity and steam to industrial customers in the region.

<span class="mw-page-title-main">Gideon Amichay</span> Israeli businessman (born 1963)

Gideon Amichay is an Israeli advertising executive, marketer and author. He is the founder and chief creative officer of No, No, No, No, No, Yes, a creative boutique in New York and Tel Aviv. He also teaches at the School of Visual Arts in New York City. From May 1994 to November 2011, he acted as the Chief Creative Officer & Joint Managing Partner at Shalmor Avnon Amichay/Y&R, Tel Aviv, Israel.

<span class="mw-page-title-main">Idan Ofer</span> Israeli business magnate and philanthropist

Idan Ofer is an Israeli billionaire businessman and philanthropist, with interests in shipping, energy, mining and sports. He is the founder of the principal of the Quantum Pacific Group, a holding company. He is majority shareholder of the Israel Corporation, listed on the Tel Aviv Stock Exchange, as well as Kenon Holdings, listed on the Tel Aviv and New York Stock Exchange. He is also the owner of the Israeli holding company Lynav Holdings and the Dutch-based Ansonia Holdings.

<span class="mw-page-title-main">Cofix</span> Coffee shop chain founded in Israel

Cofix is an Israeli coffee shop, bar and supermarket chain established in 2013 by Avi Katz, which uses a fixed price menu system. Most Cofix branches are in city centers, and other popular areas, but some are located in or next to educational institutions, such as Haifa University

Danya Cebus is an Israeli construction company. It is a subsidiary of Africa Israel Investments. It was founded in 1997. It is active in Russia, Romania, and Israel.

Natural Intelligence is an Israeli intent marketing company, that was founded in 2009 and is a leader in online multi-vertical marketplaces. The company's leading brands, Top10.com and BestMoney.com, help millions worldwide make informed decisions every day. The company specializes in user acquisition, especially via paid search, and has comparison listings in a variety of topics in fields such as personal finance, business solutions and consumer services.

<span class="mw-page-title-main">Zack Weisfeld</span> Israeli entrepreneur

Tzahi "Zack" Weisfeld is an Israeli serial entrepreneur. He is a Vice-president at Intel and the General manager of Ignite, Intel’s global start-up program. Weisfeld held several positions at Microsoft, including General Manager of Global Startups and a management member of Microsoft’s R&D Center in Israel.

<span class="mw-page-title-main">Shamir Optical Industry</span> Israeli optical lens company

Shamir Optical IndustryLtd. is an international company headquartered in Kibbutz Shamir, Israel that develops and manufactures optical lenses for eyeglasses. In 2005, the company issued dual listings, on the Tel Aviv Stock Exchange and NASDAQ, becoming the first company from the kibbutz industry to be listed on NASDAQ.

<span class="mw-page-title-main">Roy Schwartz Tichon</span> Israeli entrepreneur

Roy Schwartz Tichon is an Israeli entrepreneur, mostly known for making an alternative for public transportation on Shabbat (Saturday) in Israel. Schwartz Tichon is the chairman of "Ve Af Al Pi Chen" cooperative, which operates buses lines that changed the Status quo (Israel).

<span class="mw-page-title-main">Gali Baharav-Miara</span> Israeli lawyer and State Attorney General

Gali Baharav-Miara is an Israeli lawyer who serves as the current Attorney General of Israel. Prior to that, she served as the Tel Aviv District Attorney for Civil Affairs, and as a consultant to the law firm Tadmorת Levi & Co. She is the first female Attorney General of Israel.

Electra Consumer Products, stylized as ELECTRA CP, is an Israeli multi-industry public company which was founded in 1945. The company has divisions in the areas of electric consumer products, retail of electrical goods, food and beverages, sports and leisure, and real estate. Electra Consumer Products is traded on the Tel Aviv Stock Exchange and is a constituent company of the TA-90 Index of top shares, trading under the ticker symbol ECP. The company is part of the Elco Group.

<span class="mw-page-title-main">Haim Cohen (chef)</span> Israeli television presenter

Haim Cohen is an Israeli chef, and cookbook author.

Firebolt Analytics is a data software company, operating globally. Its main product is a cloud data warehousing platform for data engineers. Firebolt was founded and headquartered in Tel Aviv, Israel.

Userway is a digital accessibility company based in Wilmington, Delaware. The company uses AI and automation in response to legal pressure on companies to make their websites accessible. It is being traded on the Tel Aviv Stock Exchange.

<span class="mw-page-title-main">Moshe Gaon</span> Israeli businessperson

Moshe Gaon is an Israeli businessman and political consultant. Gaon is also an entrepreneur and investor in high-tech companies.

References

  1. ↑ "Prospectus of a public offering dated August 18, 2005". TASE (in Hebrew). Retrieved 2019-05-15.
  2. ↑ "Kamada Company Profile" . Retrieved May 15, 2019.
  3. ↑ Ben-Simon, Guy (2012-12-10). "Kamada enters Tel Aviv 100". כלכליסט - www.calcalist.co.il (in Hebrew). Retrieved 2019-05-15.
  4. ↑ "Fast 500 EMEA 2012 winners | Deloitte LLP". 2013-01-23. Archived from the original on 2013-01-23. Retrieved 2019-05-15.
  5. ↑ צליק, ניר (2014-05-16). "Kamada did not meet the central goal of the experiment in inhalation for hereditary emphysema patients". כלכליסט - www.calcalist.co.il (in Hebrew). Retrieved 2019-05-15.
  6. ↑ צליק, ניר (2015-05-05). ""The value of a company like Kamada is $ 1 billion"". כלכליסט - www.calcalist.co.il (in Hebrew). Retrieved 2019-05-15.
  7. ↑ Research, Center for Biologics Evaluation and (2019-04-09). "GLASSIA". FDA.
  8. ↑ "Kamada and Baxter Enter into a Strategic Agreement for the Distribution and Manufacture of Intravenous Liquid AAT to Treat Alpha-1 Antitrypsin Deficiency in the US". www.businesswire.com. 2010-08-24. Retrieved 2019-05-15.
  9. ↑ גביזון, יורם (2011-08-30). "קמהדע תמכור למדינה נסיוב נגד ארס נחשים ב-35 מיליון שקל בעשור הקרוב". TheMarker. Retrieved 2019-05-15.
  10. ↑ "Kamada to Report First Quarter 2019 Financial Results and Host Conference Call on May 14". NASDAQ.com. Retrieved 2019-05-15.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.